• Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues


Simtra BioPharma Solutions Expands Bloomington, Indiana, Operations

Simtra BioPharma Solutions, an injectable contract development and manufacturing organization, plans to expand its manufacturing operation in Bloomington, Indiana. The $250 million project is expected to create 130 jobs.

The investment will include the construction of a new 150,000-square-foot facility featuring two high-speed automated isolator syringe fill lines and a new high speed isolator vial line equipped with three 30 square meter lyophilizers. The expansion is scheduled for completion in late 2026.

"We are experiencing a broad increase in demand and need for injectable manufacturing in therapeutic classes such as GLP-1 drugs and product categories such Antibody-Drug-Conjugates as well as overall continued growth of the oncology pipeline," said Franco Negron, CEO of Simtra BioPharma Solutions. "Our customers consider our sites in Halle and Bloomington as an extension of their manufacturing network, so we are thrilled to further enhance our capabilities and resources to help them meet their respective goals. This expansion is the latest in a series of strategic, long-term investments to ensure that Simtra continues to grow with and for our customers."

Based on the company’s job creation plans, the Indiana Economic Development Corporation (IEDC) committed an investment in Simtra of up to $1.6 million in the form of incentive-based tax credits. These tax credits are performance-based, meaning the company is eligible to claim incentives once Hoosiers are hired.

“Indiana is a growing life sciences leader, advancing critical R&D and delivering life-changing pharmaceuticals and solutions for people around the world,” noted Ann Lathrop, chief strategy officer at the Indiana Economic Development Corporation (IEDC). “Simtra is an important part of this ecosystem, and the company’s expansion will catalyze quality job opportunities, economic growth, and industry momentum for years to come.”

Additionally, the Bloomington Economic Development Corporation (BEDC) supported Simtra BioPharma Solutions in its application for tax abatements.

"Simtra's expansion with this project represents a significant win for Monroe County’s economic landscape,” noted Jennifer Pearl, president of the Bloomington Economic Development Corporation. “This investment not only creates high-quality jobs but also reinforces our community's reputation as a hub for innovation and growth in the biopharmaceutical industry. We are proud to support Simtra in their endeavors, grateful to Monroe County and the state for their support of the expansion, and look forward to the continued success of this partnership."

Simtra BioPharma Solutions, a trade name of Baxter Oncology GmbH and Baxter Pharmaceutical LLC, offers world-class cGMP sterile fill/finish, technical expertise, quality service, and a uniquely collaborative approach. The expansion announcement follows the company’s recent acquisition by Advent International, a global private equity investor, and Warburg Pincus, a global growth investor.

Exclusive Research